MG
TWST icon

Michael Gelband’s Twist Bioscience TWST Stock Holding History

Michael Gelband’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,000
Closed -$1.42M – 2623
2020
Q4 		$1.42M Buy
+10,000
New +$1.11M 0.01% 689

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Michael Gelband's TWST Position: Q2 2026 in Review

Michael Gelband opened a new position in Twist Bioscience (TWST) in Q2 2026: 51,999 shares worth $5.35M. The stake represents 0.03% of the portfolio and ranks #472 among its holdings. This is a return to the name: Michael Gelband previously reported a position in TWST as recently as Q2 2025.

Michael Gelband first reported a position in TWST in Q1 2021 and has held it in 10 quarters since. The position peaked at $17.4M in Q2 2025. 334 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Michael Gelband held 51,999 shares of Twist Bioscience worth $5.35M as of Q2 2026.
  • Twist Bioscience was a new Michael Gelband position in Q2 2026.
  • Twist Bioscience made up 0.03% of Michael Gelband's portfolio in Q2 2026, its #472 holding.
  • Michael Gelband first reported a position in Twist Bioscience in Q1 2021 and has held it in 10 quarters since.
  • Michael Gelband's Twist Bioscience position peaked at $17.4M in Q2 2025.
  • 334 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.